Cunning Capital Partners, LP Edwards Lifesciences Corp Transaction History

Cunning Capital Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $458,820 - $577,530	-4,500 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $6.7 Million - $8.23 Million	-63,000 Reduced 93.33%	4,500 $6.15 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $2.27 Million - $3.04 Million	39,500 Added 141.07%	67,500 $4.67 Million
Q1 2020 Jun 15, 2020	BUY	$52.41 - $81.0 $1.47 Million - $2.27 Million	28,000 New	28,000 $5.28 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cunning Capital Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Cunning Capital Partners, LP with notifications on news.